Beta Thalassemia — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for beta thalassemia. 11 active patents protecting 2 drugs from 2+ originators. First major cliff: 2029. Daily refresh.

2
Approved drugs
11
Active US patents
33/100
Avg vulnerability
—
Annual revenue covered

Originators in Beta Thalassemia

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Chiesi 8 patents Novartis 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating beta thalassemia. Each bar = one year. Y-axis scaled to peak year (6 patents).

2
29
3
34
6
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Ferriprox
DEFERIPRONE
 Chiesi 8 62 — 2029-10-26
Exjade
DEFERASIROX
 Novartis 3 4 — 2034-11-21

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11357731 Ferriprox method of use 70 2038-10-25
11723874 Ferriprox method of use 70 2038-10-25
8703156 Ferriprox method of use 68 2029-10-26
8703156 Ferriprox method of use 68 2029-10-26
10780055 Ferriprox method of use 62 2038-10-25
10940115 Ferriprox method of use 62 2038-10-25
11458103 Ferriprox formulation 50 2038-10-25
10940116 Ferriprox formulation 42 2038-10-25
9283209 Exjade composition of matter 4 2034-11-21
9283209 Exjade composition of matter 4 2034-11-21

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9283209 Exjade composition of matter 4 2034-11-21
9283209 Exjade composition of matter 4 2034-11-21
9283209 Exjade composition of matter 4 2034-11-21
10940116 Ferriprox formulation 42 2038-10-25
11458103 Ferriprox formulation 50 2038-10-25
10780055 Ferriprox method of use 62 2038-10-25
10940115 Ferriprox method of use 62 2038-10-25
8703156 Ferriprox method of use 68 2029-10-26
8703156 Ferriprox method of use 68 2029-10-26
11723874 Ferriprox method of use 70 2038-10-25

Related